Cafepharma Today

November 20 2024 - Novo, Viking heat up MASH space with promising data at AASLD24
Novo, Viking heat up MASH space with promising data at AASLD24
Pfizer, under pressure to change, names oncology head as new R&D chief
What might a Trump administration mean for the Biosecure Act?
Sage wilts as Huntington's prospect flunks trial
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Roche’s Alzheimer’s test shows high negative predictive value
Clinical Trials Arena
Thursday, October 31, 2024 - 9:15am
tags:
Roche, diagnostics, Alzheimer's disease, Elecsys
Exactech Files for Bankruptcy in Response to 2,600 Lawsuits Over Recalled Implants
Medical Devices and Diagnostics Industry
Wednesday, October 30, 2024 - 8:52pm
tags:
Medtech, Exactech, legal, recalls, bankruptcy
AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat
Investors Business Daily
Wednesday, October 30, 2024 - 8:50pm
tags:
AbbVie, earnings, Humira, Skyrizi
Novo takes big step toward ending Ozempic, Wegovy shortages
BioPharma Dive
Wednesday, October 30, 2024 - 8:48pm
tags:
Novo Nordisk, drug shortages, obesity, Ozempic, Wegovy
Roche sees rapid amyloid clearing in Alzheimer's study, adjusts protocol after patient death
Fierce Biotech
Wednesday, October 30, 2024 - 8:47pm
tags:
Roche, Alzheimer's disease, clinical trials, trontinemab
Biogen buys in to molecular glues with Neomorph deal worth up to $1.45B
Fierce Biotech
Wednesday, October 30, 2024 - 8:45pm
tags:
Biogen, Neomorph, molecular glue, protein degradation
Biogen, Sage admit a defeat in major depression
BioPharma Dive
Wednesday, October 30, 2024 - 8:43pm
tags:
Biogen, SAGE Therapeutics, Zurzuvae, postpartum depression, major depressive disorder
Lilly shares fall as obesity drug sales miss forecasts
BioPharma Dive
Wednesday, October 30, 2024 - 11:52am
tags:
Eli Lilly, earnings, obesity, Zepbound, Mounjaro
Blue Earth Therapeutics Ltd announces completion of $76.5M Series A financing to accelerate development of next generation targeted radioligand therapies
PR Newswire
Wednesday, October 30, 2024 - 11:52am
tags:
Blue Earth Therapeutics, funding, radioligands
Edwards data show benefit of early TAVR over ‘watchful waiting’
Medtech Dive
Wednesday, October 30, 2024 - 11:48am
tags:
Medtech, Edwards Lifesciences, TAVR, aortic stenosis
GSK tries to steady the ship as Arexvy sales plummet in wake of CDC guidance changes
Fierce Pharma
Wednesday, October 30, 2024 - 11:47am
tags:
GSK, earnings, Arexvy, RSV, vaccines
A new biotech, built around protein design, springs from David Baker’s lab
BioPharma Dive
Wednesday, October 30, 2024 - 11:45am
tags:
Archon Biosciences, David Baker, funding, protein design
Spero’s stock slides after antibiotic flops in Phase II trial
Clinical Trials Arena
Wednesday, October 30, 2024 - 11:44am
tags:
Spero Therapeutics, SPR720, non-tuberculous mycobacteria pulmonary disease, clinical trials
AstraZeneca's China president faces 'ongoing investigation' by authorities in the country
Fierce Pharma
Wednesday, October 30, 2024 - 11:43am
tags:
AstraZeneca, China, Leon Wang
With Jakafi's patent cliff looming, Incyte looks to 2025 launches to bulk up revenue by decade's end
Fierce Pharma
Wednesday, October 30, 2024 - 11:42am
tags:
Incyte, Jakafi, patent cliff, Niktimvo, graft vs host disease, Monjuvi, follicular lymphoma, Zynyz, squamous cell anal carcinoma
Backlash builds against Novo’s Catalent takeover
Pharma Voice
Wednesday, October 30, 2024 - 11:40am
tags:
Novo Holdings, Novo Nordisk, Catalent, M&A, Roche
Eledon drug helps transplants 'cure' type 1 diabetes
Pharmaphorum
Wednesday, October 30, 2024 - 11:39am
tags:
Eledon Pharmaceuticals, type 1 diabetes, inslet cell transplant, tegoprubar
Novartis gets FDA okay for frontline use of Scemblix in CML
Pharmaphorum
Wednesday, October 30, 2024 - 11:38am
tags:
Novartis, CML, Scemblix, FDA
Lexicon's revised Zynquista bid in type 1 diabetes faces lingering safety questions
First Word Pharma
Tuesday, October 29, 2024 - 8:07pm
tags:
Lexicon Pharmaceuticals, type 1 diabetes, Zynquista, FDA
Most docs say pharma ads improve patient condition awareness
Medical Marketing and Media
Tuesday, October 29, 2024 - 8:05pm
tags:
physicians, pharma advertising, patients

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Down There in the Nano-Flow
In the Pipeline
Large Chains’ Position in 2025’s Part D Pharmacy Networks: Supermarkets Take the Lead in a Shrinking PDP Market
Drug Channels
CNS Drug Development: Same As It Ever Was
In the Pipeline
From Integration to AI: The Data-Driven Future of Market Access
Drug Channels
On RFK Jr. And What We're In For
In the Pipeline
Natural-Ish Product Motifs
In the Pipeline
Medicare Part D in 2025: Preferred Pharmacy Networks Fade in a Collapsing PDP Market
Drug Channels
Deuterium In Court
In the Pipeline
Drug Channels Outlook 2025 (NEW Live Video Webinar)
Drug Channels

Latest Jobs

Area Manager, Specialty Southeast
Fields, Oregon, 97710
CSL Behring
Neuroscience Account Manager - Milwaukee, WI
Milwaukee, Wisconsin, US
Lundbeck
BioPharmaceutical Account Manager - Houston South, TX
Houston, Texas, US
Lundbeck
Associate Director, Strategic Account Management -Pacific
San Francisco, California
AbbVie
Senior Director, US HIV Prevention Launch Hub Lead
Foster City, California
Gilead Sciences, Inc.
Therapy Development Manager Transcatheter Heart Valve
San Diego, California, 92189
Edwards Lifesciences
Neuroscience Account Manager (Psychiatry) - Missoula, MT
Missoula, Montana, 59812
Vanda Pharmaceuticals
Senior Account Manager IV Therapy - Northern CA / Nevada
Honolulu, Hawaii, 96814
Fresenius Kabi USA, LLC
Psychiatry Account Manager - Dayton West, OH
Oakwood, Ohio, 45873
Lundbeck
Neuroscience Account Manager (Psychiatry) - Detroit East, MI
Hamtramck, Michigan, 48212
Vanda Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information